Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Cisco who wrote (1217)	1/20/1998 1:48:00 AM
From: Frank Buck	Read Replies (1) \| Respond to of 1894

Cisco, You've got it all wrong. I do this close monitoring of the financial markets for the warden's personal account, not my own. He said that he would try to get me out early if I did well by him. I am starting to think that something is wrong! The parole board keeps turning me down even after several back to back years of strong returns. I remember the warden once saying; "One needs the conviction of a criminal to make steady, year after year healthy returns." What do you suppose he meant by that? Oh you'll never guess who I ran into today in the library. Michael Milkens ex-cell block neighbor. He said junk bonds are still "King" according to Michael. I guess they still correspond. They must have gotten tight while they were both inside.<g> BTW this guy...Milkens ex-pal...he said he was an industry banking analyst. He said he is innocent. He didn't know a thing about all those banking mergers until they were announced. The library is closed but an old night guard about to retire lets me stay longer. I am helping the prison-guards place their pension-funds. Unfortunately I got them overbought in an International Asian Fund. Many of them aren't too happy. I'm not worried. BTW can someone do me a BIG favor? I am trying to make a chess board and players out of sandstone. Can someone please mail me a geology rock-hammer? I'll provide you with an address and pay you for your inconvenience. Thanks Frank

To: Cisco who wrote (1217)	1/20/1998 1:39:00 PM
From: Frank Buck	Read Replies (2) \| Respond to of 1894

Cisco, I know you sadly regret missing the conference call because of an out of town meeting-engagement. Here are a few highlights: * NewCo venture (name will change-to OncoMedics?) will allow for joint marketing and distribution of products with the AcCell/Savant and TracCell 3000 being some of the initial key products. * The cytometric evaluation of lung sputum by the Savant will address a $3B market. The newly developed lung cancer detection device (using cytometric evaluation) will be able to detect 90% of screened lung cancer at a Stage 0 or Stage 1 phase. Presently only 10% is detected at Stage 3 phase. * The Savant cytometric diagnostic evaluation equipment will compliment and interphase with the existing AcCell/TracCell devices, and not "cannibalize" future sales of those devices as a result. * NewCo venture will reduce AccuMed operating expenses! Sakura's contribution; $2.5M cash, new product development, distribution channels, and cytopathology related inputs??. The NewCo venture is timely and it will allow for a quicker product development and marketing of the above mentioned products and jointly developed ones. * NewCo being taken public within twelve months! Because NewCo is not a developmental stage company, the effects of a rapid burn-rate of its initial cash position should not be a factor. * There is a "possibility" of a greater than 50% ownership in NewCo by AccuMed. * AccuMed should realize a positive impact on both the "Balance Sheet and Income Statement" as a result of the NewCo venture. (We had already made that assessment) AccuMed '98 R&D cost-reductions between $3M & $4M !! as a result of equity carving allocation to NewCo*. Peter Gombrich "disheartened" at current ACMI shareprice. * When Peter was asked about '97 Q-4 EPS estimates coming close to estimates...a "cum-see...cum-sa" response was given. I think the warden will like this! What is your take? Frank